Illumina To Webcast Upcoming Investor Conference
Illumina (ILMN) will participate in the UBS Global Healthcare Conference on November 10, 2026, with members of its management team.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Illumina (ILMN) will participate in the UBS Global Healthcare Conference on November 10, 2026, with members of its management team. The fireside chat is scheduled for 7:15 a.m. PT (10:15 a.m. ET). A webcast will be available through the Events & Presentations section at investor.illumina.com, with a replay archived for at least 30 days following the event.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Upcoming Investor Conference
- UBS Global Healthcare Conference on November 10, 2026
The fireside chat is scheduled for 07:15am PT (10:15am ET).
The webcast can be accessed through the Events & Presentations section of Illumina's website at investor.illumina.com. A replay will be archived on Illumina's website for at least 30 days following the event.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube.
Investors:
Conor McNamara
+1.858.291.6421
ir@illumina.com
Media:
Christine Douglass
pr@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-to-webcast-upcoming-investor-conference-302914574.html
SOURCE Illumina, Inc.